Theophylline (Theophylline Sr 200-lennon, Theophylline Sr Lennon)
Theophylline
Pharmacare limited û woodmead
Every registration of this product has been cancelled.
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 2
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Theophylline sr 200-lennon EACH TABLET CONTAINS ANHYDROUS THEOPHYLLINE 200 mg | Not listed | 29033029/10.2.2/0330 | Cancelled | Not determined | None |
| Theophylline sr 300 - lennon EACH TABLET CONTAINS ANHYDROUS THEOPHYLLINE 300,0 mg | 300 - | 29033129/10.2.2/0331 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Theophylline
- and its derivatives, unless listed elsewhere in the Schedules, and preparations intended for injection. (S2)
Consolidated Schedules 06 July 2026, lines 8173 to 8174
S2: Theophylline
- and its derivatives, unless listed in another Schedule, and except in preparations for injection.
Consolidated Schedules 06 July 2026, line 2723
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
1,3-Dimethyl-7H-purine-2,6-dione
Drag to rotate. Structure from PubChem CID 2153.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.